Developing Fusion Proteins for Therapeutics
In a recent webcast, noted pharmaceutical experts discussed the value of using fusion proteins for therapeutic treatments — and the challenges that manufacturers need to overcome.
What’s Happening
Single-use bioreactors add to Laureate Pharma’s flexibility; a new contract manufacturing agreement kicks off; and events provide educational opportunities for scientists and manufacturers.
Fusion Proteins: Productivity, Production and Product Development
Dr. Howard L. Levine, Founder, President, and Principal Consultant for BioProcess Technology Consultants, answers some important questions about fusion proteins.
Purifying Fusion Proteins: Expect the Unexpected
In this case study, learn how Laureate Pharma designed a customized process for purifying fusion proteins.
“If we all did the things we are capable of doing, we would literally astound ourselves.”
— Thomas A. Edison
cGMP CONDITIONS. ON TIME DELIVERY.
WITH LAUREATE PHARMA, IT’S IN THE VIAL.TM